Congratulations to Rayanna Birtch on winning first price for her poster presentation at the Canadian Undergraduate Conference on Healthcare on November 9th. 2019.  Rayanna is in the combined BSc-MSc program with Dr. Peter Greer in the Department of Pathology and Molecular Medicine.  Her project explores functional interactions between the adaptor protein Ezrin and the cancer stem cell marker CD44 in highly aggressive triple negative breast cancer.

THE TENTH NATHAN KAUFMAN VISITING LECTURER

SUSAN DONE
FCCMG, FRCPath, PhD, MBA, MRCPath, FRCPC, MB. B.Chir., Associate Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
Pathologist and Researcher, UHN

"NOT ALL BREAST CANCER CELLS ARE CREATED EQUAL"

Tuesday, October 22, 2019
4:00 pm
Room 104, Richardson Laboratory
88 Stuart Street, Queen's University

The Ontario Molecular Pathology Research Network (OMPRN) annual "Pathology Matters" meeting took place on Monday at the Canada Science and Technology Museum in Ottawa.

Our Department was extremely well represented at the meeting. Nearly a quarter of the roughly 100 attendees were from Queen's, Queen's Faculty members contributed heavily to planning and running the meeting, and three of the four "Outstanding Poster Awards" went to Queen's trainees.

I am pleased to announce the appointment of Dr. Tricia Cottrell as an Assistant Professor in the Department of Pathology and Molecular Medicine.

Tricia joins us from the Johns Hopkins University School of Medicine where she completed an MD, a PhD in rheumatology, residency training in Anatomic Pathology, and a Postdoctoral Fellowship in immuno-oncology. Tricia completed her undergraduate training and a year as a Research Fellow at Washington University in St. Louis.

Emerging research in Dr. Peter Greer's laboratory shows that calpain proteases promote cancer metastasis, which is responsible for most cancer deaths. With funds from a new five year CIHR grant we are exploring calpains as novel therapeutic targets in the treatment of breast and ovarian cancer. This exciting research involves a range of molecular genetic approaches (including CRISPR gene targeting) as well as preclinical models of breast and ovarian cancer.

The Department of Pathology and Molecular Medicine is pleased to announce the appointment of Dr. Anna Panchenko to a tenured position at Queen's University.

Dr. Panchenko will be assuming a leadership role in the future development of computational biophysics and bioinformatics at Queen's. She will have cross-appointments in the School of Computing and the Department of Biomedical and Molecular Sciences.